In a recent research report by Maximize Market Research, the Pharmaceutical Hot Melt Extrusion Equipment market is expected to surpass US $37.62 million by the year 2027, from US $29.82 million in 2020.
The Pharmaceutical Hot Melt Extrusion Equipment market Trends:
Despite a huge decline in the sales of products during the initial phase of pandemic spread and lockdown restrictions all over the region, the market is observed to pick up at a quick pace, registering a CAGR of almost 3.95% during the tenure of 2021-2027.
The report published by Maximize encompasses the market dynamics which could affect the market growth of pharmaceutical hot melt extrusion equipment in the region, the Value-Chain Analysis, and Porter’s Analysis for the pharmaceutical hot melt extrusion equipment market at a global level.
The study is consolidated based on segments and further into sub-segments, based on Type (RAM extruders, Radial screen equipment, Roll and screw extruders (single-screw, twin-screw, and multi-screw)).
Lastly, the market research report provides a regional comparison and a complete country-level analysis for the latest trends, along with the major key players – Baker Perkins Ltd., Coperion GmbH, Gabler GmbH & Co. KG, Milacron Holdings Corp., Leistritz Advanced Technologies Corp., Thermo Fisher Scientific Inc., Xtrutech Ltd., Catalent’s OptiMelt, AbbVie, Foster, Midas Pharma, PMC Isochem, Pensatech Pharma GmbH, PozLab, Green Ridge Consulting, PriviLS LLP, and Others.
You can browse the market data tables and figures spread through a comprehensive research report and an in-depth TOC on the “Global Pharmaceutical Hot Melt Extrusion Equipment Market.”
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Office no. 4,
Navale IT Zone Phase-2,
Mumbai -Bangalore Bypass Highway,
Pune- 411041
Maharashtra, India
+91 9607195908